Clincosm LogoSign in Get a demo

insulinoma

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diagnosing and Treating Low Blood Sugar Levels

Recruiting
  • Hypoglycemia
  • Insulinoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)

    Recruiting
    • Congenital Hyperinsulinism
    • Insulinoma
    • Fluorodopa F 18
    • Fort Worth, Texas
      Cook Children's Medical Center
    Dec 8, 2022

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Gastrinoma, Glucagonoma, Insulinoma Trial in United States (temozolomide, capecitabine, laboratory biomarker analysis)

    Active, not recruiting
    Has Results
    • Gastrinoma
    • +6 more
    • Anaheim, California
    • +322 more
    Oct 14, 2022

    Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +6 more
    • Vancouver, British Columbia, Canada
      BC Cancer
    Aug 19, 2022

    Insulinoma Trial in Fuzhou (68Ga-NOTA-exendin-4)

    Recruiting
    • Insulinoma
    • Fuzhou, Fujian, China
      Department of Nuclear Medicine, First Affiliated Hospital of Fuj
    Jul 29, 2022

    Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

    Completed
    Has Results
    • Gastrinoma
    • +8 more
    • Scottsdale, Arizona
    • +4 more
    Nov 15, 2021

    Insulinoma Trial in Beijing ([68Ga]Ga-HBED-CC-exendin-4, [68Ga]Ga-NOTA-exendin-4)

    Recruiting
    • Insulinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 2, 2021

    Insulinoma Trial (68Ga-NODAGA-exendin 4 PET/CT)

    Completed
    • Insulinoma
    • 68Ga-NODAGA-exendin 4 PET/CT
    • (no location specified)
    Jun 15, 2021

    Congenital Hyperinsulinism, Insulinoma, Hyperinsulinism Trial (Pasireotide 0.6Mg Solution for Injection, Saline Solution)

    Withdrawn
    • Congenital Hyperinsulinism
    • +2 more
    • Pasireotide 0.6Mg Solution for Injection
    • Saline Solution
    • (no location specified)
    May 12, 2021

    Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

    Completed
    Has Results
    • Gastrinoma
    • +8 more
    • Stanford, California
      Stanford University Medical Center
    Apr 8, 2021

    Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )

    Terminated
    Has Results
    • Gastrinoma
    • +6 more
    • Boston, Massachusetts
      Ecog-Acrin
    Dec 1, 2020

    Hypoglycemia, Reactive, Hypoglycaemia Night, Hypoglycemia Non-Diabetic Trial in London (use of continuous glucose monitoring)

    Unknown status
    • Hypoglycemia, Reactive
    • +9 more
    • use of continuous glucose monitoring
    • London, United Kingdom
      St Bartholomew's Hospital, dept of endocrinology
    Jun 29, 2020

    Insulinoma Trial in Nanjing (68Ga-NOTA-MAL-Cys39-exendin-4)

    Unknown status
    • Insulinoma
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Dec 1, 2019

    Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)

    Withdrawn
    • Gastrinoma
    • +5 more
    • dovitinib lactate
    • +2 more
    • (no location specified)
    Jul 18, 2017

    Insulinoma, Nesidioblastosis Trial in Beijing (68Ga-NOTA-exendin-4)

    Unknown status
    • Insulinoma
    • Nesidioblastosis
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 24, 2015

    Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

    Completed
    • Hyperinsulinism
    • +2 more
    • 111In-exendin-4 imaging
    • Basel, Basel-Stadt, Switzerland
      University Hospital Basel, Institute of Nuclear Medicine
    Jan 8, 2015

    Insulinoma Trial in Nanning (EUS-guided ethanol ablation)

    Unknown status
    • Insulinoma
    • EUS-guided ethanol ablation
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Apr 22, 2014

    Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

    Completed
    • Advanced Adult Primary Liver Cancer
    • +126 more
    • recombinant interleukin-12
    • ABI-007/carboplatin/trastuzumab
    • Columbus, Ohio
      Ohio State University Medical Center
    Feb 27, 2013

    Insulinoma Trial run by the NIDDK (Intraoperative ultrasound)

    Completed
    • Insulinoma
    • Intraoperative ultrasound
    • Bethesda, Maryland
      National Institute of Diabetes and Digestive and Kidney Diseases
    Mar 3, 2008